<DOC>
	<DOCNO>NCT01920711</DOCNO>
	<brief_summary>The purpose study evaluate effect LCZ696 compare valsartan reduction cardiovascular death heart failure ( HF ) hospitalization patient HF preserve ejection fraction .</brief_summary>
	<brief_title>Efficacy Safety LCZ696 Compared Valsartan , Morbidity Mortality Heart Failure Patients With Preserved Ejection Fraction</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Left ventricular ejection fraction ( LVEF ) ≥45 % echo screening epoch within 6 month prior study entry . Symptom ( ) heart failure ( HF ) require treatment diuretic ( ) HF least 30 day prior study entry . Current symptom ( ) HF Structural heart disease ( left atrial enlargement leave ventricular hypertrophy ) document echocardiogram . Elevated NTproBNP Any prior measurement LVEF &lt; 40 % . Acute coronary syndrome ( include MI ) , cardiac surgery , major CV surgery within 3 month , urgent percutaneous coronary intervention within 3 month elective PCI within 30 day prior entry . Any clinical event within 6 month prior entry could reduce LVEF ( e.g. , MI , CABG ) , unless echo measurement perform event confirms LVEF ≥45 % . Current acute decompensated HF require therapy . Patients require treatment 2 following : angiotensin convert enzyme inhibitor ( ACEI ) , angiotensin receptor blocker ( ARB ) renin inhibitor . Alternative reason shortness breath : significant pulmonary disease severe COPD , hemoglobin ( Hgb ) &lt; 10 g/dl , body mass index ( BMI ) &gt; 40 kg/m2 . Systolic blood pressure ( SBP ) ≥ 180 mmHg entry , SBP &gt; 150 mmHg &lt; 180 mmHg entry unless patient receive 3 antihypertensive drug , SBP &lt; 110 mmHg entry . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Heart failure , preserve ejection fraction , diastolic heart failure</keyword>
</DOC>